Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
- Type
- Expression of concern
- Notice date
- 4/1/2022 0:00
- Journal
- Journal of the National Cancer Institute
- Publisher
- Oxford University Press
- Notice DOI
- 10.1093/jnci/djac065
- Original paper DOI
- 10.1093/jnci/djac015